BioSpace News Archive

Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.708 billion during the fourth quarter of 2020. This represents a decline of (6.8) percent on a reported basis, (8.3) percent on an operational 1 basis and (8.0) percent on an organic 2 basis, all compared to the prior year period.

Epinephrine or adrenaline is a hormone secreted by adrenal glands in the blood stream. It is one of the two common hormones (the other being glucagon) that is responsible for glycogen breakdown.

Gene expression panel helps in profiling of hundreds of genes, proteins, miRNAs, and facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation.

RF microneedling is a minimally invasive technique, in which the microneedling procedure is carried out with radio frequency energy to rejuvenate the appearance of the skin.

Filters are connected in numerous phases during the manufacture of small molecular drugs, which is termed as active pharmaceutical ingredients, as well.

Multi-year collaboration will use artificial intelligence (AI) and deep learning to accelerate the invention of new, more sustainable products and technologies for growers

Development to begin immediately targeting vaccine availability in 2022, subject to regulatory approval

Oversubscribed transatlantic fund to invest in US, UK and European life science companies developing innovative therapeutics with potential to significantly improve human health

XPhyto Therapeutics Corp. is pleased to announce that XPhyto Laboratories Inc., its wholly owned Alberta subsidiary, has signed an agreement with Applied Pharmaceutical Innovation for the synthesis of pharmaceutical grade psychedelic compounds and the parallel development of the standard operating procedures necessary to obtain regulatory approval for the respective commercial production process.

Anova Enterprises, Inc. (Anova), an organization dedicated to accelerating promising treatments to market with its transformative AnovaOS™ technology platform, and the industry’s first collaborative ‘learning system,’ and Corlexia Clinical Services, a contract research organization focused on complex clinical trials for patients with complex neurology and oncology diseases today announced the acquisition of Corlexia by Anova.